View in EDS HTML Full Text PDF Full Text

Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.

Saved in:
Bibliographic Details
Title: Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.
Authors: Kokaliaris C; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland. christos.kokaliaris@roche.com., Evans R; Visible Analytics, Oxford, UK., Hawkins N; Visible Analytics, Oxford, UK.; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK., Mahajan A; Bridge Medical Consulting Ltd, London, UK., Scott DA; Visible Analytics, Oxford, UK., Sutherland CS; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland., Nam J; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland., Sajeev G; Analysis Group, Inc, Boston, MA, USA.
Source: Advances in therapy [Adv Ther] 2024 Jun; Vol. 41 (6), pp. 2414-2434. Date of Electronic Publication: 2024 May 05.
Publication Type: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38705943
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kokaliaris+C%22">Kokaliaris C</searchLink>; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland. christos.kokaliaris@roche.com.<br /><searchLink fieldCode="AU" term="%22Evans+R%22">Evans R</searchLink>; Visible Analytics, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Hawkins+N%22">Hawkins N</searchLink>; Visible Analytics, Oxford, UK.; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Mahajan+A%22">Mahajan A</searchLink>; Bridge Medical Consulting Ltd, London, UK.<br /><searchLink fieldCode="AU" term="%22Scott+DA%22">Scott DA</searchLink>; Visible Analytics, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Sutherland+CS%22">Sutherland CS</searchLink>; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nam+J%22">Nam J</searchLink>; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sajeev+G%22">Sajeev G</searchLink>; Analysis Group, Inc, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2024 Jun; Vol. 41 (6), pp. 2414-2434. <i>Date of Electronic Publication: </i>2024 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38705943
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-024-02845-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2414
    Titles:
      – TitleFull: Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kokaliaris C
      – PersonEntity:
          Name:
            NameFull: Evans R
      – PersonEntity:
          Name:
            NameFull: Hawkins N
      – PersonEntity:
          Name:
            NameFull: Mahajan A
      – PersonEntity:
          Name:
            NameFull: Scott DA
      – PersonEntity:
          Name:
            NameFull: Sutherland CS
      – PersonEntity:
          Name:
            NameFull: Nam J
      – PersonEntity:
          Name:
            NameFull: Sajeev G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1